Exact Sciences Corp (EXAS) - Product Pipeline Analysis, 2020 Update



Exact Sciences Corp (Exact Sciences) is a molecular diagnostic company that focuses on the development of tests for various types of cancers. The companys flagship product, Cologuard test is a US FDA approved non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the early detection of colorectal cancer and pre-cancer. It utilizes a multi-target approach to detect DNA and hemoglobin biomarkers related with colorectal cancer. The company also offers Oncotype DX gene expression tests for prostate, breast, and colon cancers; and Oncotype DX AR-V7 Nucleus Detect test, a liquid-based test designed for advanced stage prostate cancer. It operates manufacturing and laboratory facilities in Madison, Wisconsin to process Cologuard tests. Exact Sciences is headquartered in Madison, Wisconsin, the US.

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Exact Sciences Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company




Exact Sciences Corp Company Overview
Exact Sciences Corp Company Snapshot
Exact Sciences Corp Pipeline Products and Ongoing Clinical Trials Overview
Exact Sciences Corp Pipeline Analysis Overview
Business Description
Exact Sciences Corp - Key Facts
Exact Sciences Corp - Major Products and Services
Exact Sciences Corp Pipeline Products by Development Stage
Exact Sciences Corp Ongoing Clinical Trials by Trial Status
Exact Sciences Corp Pipeline Products Overview
ActiveTargeting Assay
ActiveTargeting Assay Product Overview
Blood-based Lung Cancer Screening Test
Blood-based Lung Cancer Screening Test Product Overview
Cologuard 2.0
Cologuard 2.0 Product Overview
Diagnostic Assay - Liver Cancer
Diagnostic Assay - Liver Cancer Product Overview
DNA Biomarkers - Hepatocellular Carcinoma
DNA Biomarkers - Hepatocellular Carcinoma Product Overview
DNA Integrity Assay
DNA Integrity Assay Product Overview
Idylla IVD Oncotype DX Breast Recurrence Score Test
Idylla IVD Oncotype DX Breast Recurrence Score Test Product Overview
Idylla IVD Oncotype DX Breast Recurrence Score Test Clinical Trial
Liquid Biopsy Test - Bladder Cancer
Liquid Biopsy Test - Bladder Cancer Product Overview
Liquid Biopsy Test - Breast Cancer
Liquid Biopsy Test - Breast Cancer Product Overview
Liquid Biopsy Test - Esophageal Cancer
Liquid Biopsy Test - Esophageal Cancer Product Overview
Liquid Biopsy Test - Kidney Cancer
Liquid Biopsy Test - Kidney Cancer Product Overview
Liquid Biopsy Test - Liver Cancer
Liquid Biopsy Test - Liver Cancer Product Overview
Liquid Biopsy Test - Lymphoma
Liquid Biopsy Test - Lymphoma Product Overview
Liquid Biopsy Test - Melanoma
Liquid Biopsy Test - Melanoma Product Overview
Liquid Biopsy Test - Ovarian Cancer
Liquid Biopsy Test - Ovarian Cancer Product Overview
Liquid Biopsy Test - Pancreatic Cancer
Liquid Biopsy Test - Pancreatic Cancer Product Overview
Liquid Biopsy Test - Prostate Cancer
Liquid Biopsy Test - Prostate Cancer Product Overview
Liquid Biopsy Test - Stomach Cancer
Liquid Biopsy Test - Stomach Cancer Product Overview
Liquid Biopsy Test - Uterine Cancer
Liquid Biopsy Test - Uterine Cancer Product Overview
LungVantage Test
LungVantage Test Product Overview
Viomics Diagnostic Assay - Breast Cancer
Viomics Diagnostic Assay - Breast Cancer Product Overview
Viomics Diagnostic Assay - Pancreatic Cancer
Viomics Diagnostic Assay - Pancreatic Cancer Product Overview
Exact Sciences Corp - Key Competitors
Exact Sciences Corp - Key Employees
Exact Sciences Corp - Key Employee Biographies
Exact Sciences Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Exact Sciences Corp, Recent Developments
Feb 11, 2020: Exact Sciences announces fourth-quarter 2019 results
Jan 14, 2020: Paradigm appoints Melissa Dunn as Chief Sales Officer of Catastrophic Care Management Division
Jan 12, 2020: Exact Sciences announces preliminary fourth quarter 2019 results
Nov 20, 2019: Oncotype DX Breast Recurrence Score reveals sex-related differences in mortality prediction in patients with early-stage ER-positive breast cancer
Nov 11, 2019: Exact Sciences completes acquisition of Genomic Health for $2.8bn
Oct 29, 2019: Exact Sciences reports third-quarter revenue growth of 85 percent to $219 million
Oct 29, 2019: Exact Sciences presents new stool-based Colorectal Cancer screening performance data, initiates prospective screening study
Oct 15, 2019: Exact Sciences to study Cologuard in real-world setting
Sep 23, 2019: Cologuard gains FDA approval for use in younger americans, ages 45 to 49
Sep 10, 2019: Cologuard helps more people get screened in a cost-effective way
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables


Exact Sciences Corp Pipeline Products and Ongoing Clinical Trials Overview
Exact Sciences Corp Pipeline Products by Equipment Type
Exact Sciences Corp Pipeline Products by Indication
Exact Sciences Corp Ongoing Clinical Trials by Trial Status
Exact Sciences Corp, Key Facts
Exact Sciences Corp, Major Products and Services
Exact Sciences Corp Number of Pipeline Products by Development Stage
Exact Sciences Corp Pipeline Products Summary by Development Stage
Exact Sciences Corp Ongoing Clinical Trials by Trial Status
Exact Sciences Corp Ongoing Clinical Trials Summary
ActiveTargeting Assay - Product Status
ActiveTargeting Assay - Product Description
Blood-based Lung Cancer Screening Test - Product Status
Blood-based Lung Cancer Screening Test - Product Description
Cologuard 2.0 - Product Status
Cologuard 2.0 - Product Description
Diagnostic Assay - Liver Cancer - Product Status
Diagnostic Assay - Liver Cancer - Product Description
DNA Biomarkers - Hepatocellular Carcinoma - Product Status
DNA Biomarkers - Hepatocellular Carcinoma - Product Description
DNA Integrity Assay - Product Status
DNA Integrity Assay - Product Description
Idylla IVD Oncotype DX Breast Recurrence Score Test - Product Status
Idylla IVD Oncotype DX Breast Recurrence Score Test - Product Description
Idylla IVD Oncotype DX Breast Recurrence Score Test - An Assessment of the Biological and Clinical Effects of Palbociclib (PD 0332991) with Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Patients with Premenopausal Estrogen-receptor Positive/HER2-Negative Primary Breast Cancer
Liquid Biopsy Test - Bladder Cancer - Product Status
Liquid Biopsy Test - Bladder Cancer - Product Description
Liquid Biopsy Test - Breast Cancer - Product Status
Liquid Biopsy Test - Breast Cancer - Product Description
Liquid Biopsy Test - Esophageal Cancer - Product Status
Liquid Biopsy Test - Esophageal Cancer - Product Description
Liquid Biopsy Test - Kidney Cancer - Product Status
Liquid Biopsy Test - Kidney Cancer - Product Description
Liquid Biopsy Test - Liver Cancer - Product Status
Liquid Biopsy Test - Liver Cancer - Product Description
Liquid Biopsy Test - Lymphoma - Product Status
Liquid Biopsy Test - Lymphoma - Product Description
Liquid Biopsy Test - Melanoma - Product Status
Liquid Biopsy Test - Melanoma - Product Description
Liquid Biopsy Test - Ovarian Cancer - Product Status
Liquid Biopsy Test - Ovarian Cancer - Product Description
Liquid Biopsy Test - Pancreatic Cancer - Product Status
Liquid Biopsy Test - Pancreatic Cancer - Product Description
Liquid Biopsy Test - Prostate Cancer - Product Status
Liquid Biopsy Test - Prostate Cancer - Product Description
Liquid Biopsy Test - Stomach Cancer - Product Status
Liquid Biopsy Test - Stomach Cancer - Product Description
Liquid Biopsy Test - Uterine Cancer - Product Status
Liquid Biopsy Test - Uterine Cancer - Product Description
LungVantage Test - Product Status
LungVantage Test - Product Description
Viomics Diagnostic Assay - Breast Cancer - Product Status
Viomics Diagnostic Assay - Breast Cancer - Product Description
Viomics Diagnostic Assay - Pancreatic Cancer - Product Status
Viomics Diagnostic Assay - Pancreatic Cancer - Product Description
Exact Sciences Corp, Key Employees
Exact Sciences Corp, Key Employee Biographies
Exact Sciences Corp, Subsidiaries
Glossary

List Of Figures


Exact Sciences Corp Pipeline Products by Equipment Type
Exact Sciences Corp Pipeline Products by Development Stage
Exact Sciences Corp Ongoing Clinical Trials by Trial Status

Exact Sciences Corp (EXAS) - Product Pipeline Analysis, 2019 Update

Exact Sciences Corp (EXAS) - Product Pipeline Analysis, 2019 Update market research report available in single user pdf license with Aarkstore Enterprise at USD 750

USD 750 View Report

Exact Sciences Corp (EXAS) - Product Pipeline Analysis, 2017 Update

Exact Sciences Corp (Exact) is a molecular diagnostic company that focuses on the early detection and prevention of various cancers. The companys flagship product, Cologuard test is a non-invasive stool-based

USD 750 View Report

Edwards Lifesciences Corp (EW) - Product Pipeline Analysis, 2020 Update

Edwards Lifesciences Corp (Edwards Lifesciences) is a medical technology company that develops, manufactures and markets devices for structural heart disease, critical care and surgical monitoring. The companys products include surgical

USD 750 View Report

COVID-19 Impact on Edwards Lifesciences Corp.s Revenue and Operations (Medical Devices)

COVID-19 Impact on Edwards Lifesciences Corp.s Revenue and Operations (Medical Devices)Edwards Lifesciences Corp. is a medical technology company that engages in the designing, developing, manufacturing and marketing of medical devices

USD 495 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available